MAPLe® for a detailed diagnosis and targeted treatment of the pelvic floor.

With the MAPLe you will understand the pelvic floor!

MAPLe®

A targeted and effective treatment of Pelvic Floor Dysfunctions starts with an accurate diagnosis (EMG / ElectroMyoGraphy).

With MAPLe one can really make the difference for the patient and take the diagnosis and treatment of Pelvic Floor Dysfunctions in the hospital and pelvic floor physiotherapy practice to a higher level.

MAPLe is developed for better understanding of the pelvic floor! Through the accurate diagnosis it is possible to make a specific treatment plan.

MAPLe provides targeted biofeedback of individual muscles on different sides and depths in the pelvic floor.

The device can also give local electrostimulation (EMS / ElectroMyoStimulation). This allows to provide precise and targeted stimulation.

The MAPLe probe is single patient/multiple use by pelvic physiotherapists, urologists, incontinence nurses and gynecologists.

• High Definition 24-point measurements for accurate diagnosis and treatment.

• Scientifically proven and substantiated by studies in the Netherlands, Belgium, UK and Germany.

• Easy to operate for diagnosis, biofeedback and electrostimulation.

• Actively used by more than 75% of all pelvic physiotherapists and recommended by Dutch MOH.

MAPLe is developed in 2015 in close collaboration with the Leiden University Medical Centre in the Netherlands and is patented in US, EU, Canada and Australia.

The product is used as a permanent module in several renowned medical training institutes and supported by Dutch branch organizations and Key Opinion Leaders.

MAPLe is winner of the MEDICA innovation award for most innovative Medical Device and winner of the “Look Good Feel Good Award 2018” by the ACA (Association for Continence Advice) in UK.

MAPLe is CE marked (Medical Device Class 2a) in Europe for diagnosis and treatment of Pelvic Floor Dysfunction.

Novuqare works together with healthcare professionals and patients on research and projects to initiate innovations and to develop clinically relevant solutions.

Since our founding in 2011 we have developed long-term collaborations with our partners Philips Healthcare and GETINGE Group.

The unique products we develop and produce for these partners are sold under their names.